Search
CPRIT honors UTSW’s Argenbright with Texans Conquer Cancer Award: Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2026/oct-cprit-Argenbright-texans-conquer-cancer-award.html
Keith Argenbright, M.D., Director of the Moncrief Cancer Institute at UT Southwestern Medical Center, received the 2026 Texans Conquer Cancer Award.
UT Southwestern women’s groups earn national leadership award: Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2023/oct-yin-womens-groups-earn-national-leadership-award.html
UT Southwestern Medical Center has been recognized for its decades of commitment to developing female leaders in medicine and science and its far-reaching impact in supporting and advancing women’s careers.
UTSW researcher receives NIH Director’s New Innovator Award: Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2023/oct-maddipati-nih-directors-new-innovator-award.html
Ravikanth Maddipati, M.D., Assistant Professor of Internal Medicine and in Children’s Medical Center Research Institute at UT Southwestern, has been awarded $1.5 million from the National Institutes of Health (NIH) to support research investigating positional heterogeneity in cancer, or how tumors in the same organ can behave differently based on where they form.
UT Southwestern brings first-of-its-kind radiation oncology to new $177M campus in Fort Worth Medical District : Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2024/nov-rad-onc-ft-worth-medical-district.html
To meet the growing demands for cancer treatment in Tarrant County and surrounding areas, UT Southwestern Medical Center is expanding its cancer services in the Fort Worth Medical District with construction of a new two-story Radiation Oncology campus that will house the city’s first MRI-guided precision radiation treatment.
Tumor mutation associated with drug-resistant liver cancer, UT Southwestern study finds: Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2023/june-tumor-mutation-drug-resistant-liver-cancer.html
A genetic marker discovered by UT Southwestern Medical Center researchers could help physicians predict which patients with hepatocellular carcinoma are most likely to develop resistance to the drug lenvatinib. The finding, published in the journal Gastroenterology, may lead to alternative treatments for the most common form of liver cancer.
Transfer RNA regulates messenger RNA degradation: Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2024/nov-transfer-rna-regulates-messenger-rna-degradation.html
Transfer RNA (tRNA), a genetic molecule well known for its contribution in reading the instructions for building proteins, is also key in regulating how long those instructions persist in cells, a new study by UT Southwestern Medical Center researchers shows.
End-of-life care more aggressive for cancer patients with defibrillators: Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2025/jan-end-of-life-care-more-aggressive-cancer-patients.html
Patients with advanced cancer who also had cardiac defibrillators were more likely than those without these implants to receive aggressive end-of-life care, a team led by UT Southwestern Medical Center researchers found in a new study.
Repurposed drug has promising efficacy in non-small cell lung cancer: Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2024/dec-efficacy-non-small-cell-lung-cancer.html
An FDA-approved drug used to treat multiple myeloma and lymphoma also shrank tumors in non-small cell lung cancer (NSCLC) with KRAS mutations, a clinical trial led by UT Southwestern Harold C. Simmons Comprehensive Cancer Center researchers showed.
Children’s Research Institute at UT Southwestern scientists identify feature of aggressive non-small cell lung cancer: Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2025/feb-cri-utsw-aggressive-non-small-cell-lung-cancer.html
In localized non-small cell lung cancer (NSCLC), a tumor’s ability to use carbon from glucose to feed the tricarboxylic acid (TCA) cycle predicts cancer spread beyond the lung, months to years before metastases are clinically apparent. According to this new research from Children’s Medical Center Research Institute at UT Southwestern (CRI) published in Cancer Discovery, tumors with this metabolic activity result in early patient death.
Experts call for more clinical trials on alcohol use, liver disease: Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2024/june-clinical-trials-alcohol-use-liver-disease.html
More clinical research is needed to investigate how reducing alcohol consumption in patients with alcohol-related liver disease (ALD) may slow disease progression and improve outcomes, according to an international task force of experts from more than two dozen institutions including UT Southwestern Medical Center.